Delisting risk
GOVX · NASDAQ · Biotechnology

GeoVax Labs

Clinical developer of an mpox/smallpox vaccine and gene-directed therapy for head-and-neck cancer.

$0.6400
After-hours close−0.08 (−11.22%)
At close$0.7209(+0.54%)
DateEstimateReportedSurprise
Nov 2026−$1.03
Jul 2026−$2.16−$0.97+55.1%
May 2026−$1.60−$2.62−63.7%
Apr 2026−$4.71−$2.29+51.3%
Nov 2025−$6.00−$7.75−29.2%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 2025
May 2025
Mar 2025
Nov 2024
Aug 2024
May 2024
Feb 2024
Nov 2023
Aug 2023
May 2023
Mar 2023
Mar 2023
Nov 2022
Aug 2022
Apr 2022
Mar 2022
Nov 2021
Aug 2021
May 2021
Mar 2021
Nov 2020
Aug 2020
May 2020
Dec 2019
Nov 2019
Aug 2019
May 2019
Mar 2019
Nov 2018
Aug 2018
May 2018
Mar 2018
Nov 2017
Aug 2017
May 2017
Mar 2017
Nov 2016
Aug 2016
May 2016
Mar 2016
Nov 2015
Report dateEPS estEPSSurpriseRevenue estRevenueSurprise
Nov 12, 2026−$1.03
Jul 27, 2026−$2.16−$0.97+55.1%
May 14, 2026−$1.60−$2.62−63.7%
Apr 2, 2026−$4.71−$2.29+51.3%$1.0M
Nov 13, 2025−$6.00−$7.75−29.2%

The latest year is open to everyone — the 41 quarters behind it read with an account.

Sign in
Jul 28, 2025
May 1, 2025
Mar 27, 2025
Nov 12, 2024
Aug 6, 2024
May 14, 2024
Feb 29, 2024
Nov 8, 2023
Aug 9, 2023
May 4, 2023
Mar 23, 2023
Mar 8, 2023
Nov 9, 2022
Aug 3, 2022
Apr 27, 2022
Mar 9, 2022
Nov 11, 2021
Aug 11, 2021
May 6, 2021
Mar 23, 2021
Nov 5, 2020
Aug 10, 2020
May 5, 2020
Dec 31, 2019
Nov 7, 2019
Aug 14, 2019
May 13, 2019
Mar 27, 2019
Nov 8, 2018
Aug 7, 2018
May 3, 2018
Mar 23, 2018
Nov 9, 2017
Aug 7, 2017
May 8, 2017
Mar 24, 2017
Nov 11, 2016
Aug 5, 2016
May 4, 2016
Mar 16, 2016
Nov 12, 2015